187 related articles for article (PubMed ID: 25447825)
1. Stabilization of amorphous paracetamol based systems using traditional and novel strategies.
Martínez LM; Videa M; López-Silva GA; de Los Reyes CA; Cruz-Angeles J; González N
Int J Pharm; 2014 Dec; 477(1-2):294-305. PubMed ID: 25447825
[TBL] [Abstract][Full Text] [Related]
2. An investigation into the effects of thermal history on the crystallisation behaviour of amorphous paracetamol.
Qi S; Avalle P; Saklatvala R; Craig DQ
Eur J Pharm Biopharm; 2008 May; 69(1):364-71. PubMed ID: 18036792
[TBL] [Abstract][Full Text] [Related]
3. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Stability of New Co-Amorphous Drug Binary Systems: Study of Glass Transitions as a Function of Composition and Shelf Time.
Martínez LM; Videa M; Sosa NG; Ramírez JH; Castro S
Molecules; 2016 Dec; 21(12):. PubMed ID: 27983640
[TBL] [Abstract][Full Text] [Related]
5. An investigation into the influence of counterion on the properties of some amorphous organic salts.
Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous improvement of solubility and permeability by fabricating binary glassy materials of Talinolol with Naringin: Solid state characterization, in-vivo in-situ evaluation.
Teja A; Musmade PB; Khade AB; Dengale SJ
Eur J Pharm Sci; 2015 Oct; 78():234-44. PubMed ID: 26253355
[TBL] [Abstract][Full Text] [Related]
7. Rheology and molecular mobility of amorphous blends of citric acid and paracetamol.
Hoppu P; Hietala S; Schantz S; Juppo AM
Eur J Pharm Biopharm; 2009 Jan; 71(1):55-63. PubMed ID: 18656536
[TBL] [Abstract][Full Text] [Related]
8. Phase separation in coamorphous systems: in silico prediction and the experimental challenge of detection.
Pajula K; Wittoek L; Lehto VP; Ketolainen J; Korhonen O
Mol Pharm; 2014 Jul; 11(7):2271-9. PubMed ID: 24824610
[TBL] [Abstract][Full Text] [Related]
9. Investigations on the effect of different cooling rates on the stability of amorphous indomethacin.
Karmwar P; Boetker JP; Graeser KA; Strachan CJ; Rantanen J; Rades T
Eur J Pharm Sci; 2011 Oct; 44(3):341-50. PubMed ID: 21884789
[TBL] [Abstract][Full Text] [Related]
10. High pressure differential scanning calorimetry investigations on the pressure dependence of the melting of paracetamol Polymorphs I and II.
Ledru J; Imrie CT; Pulham CR; Céolin R; Hutchinson JM
J Pharm Sci; 2007 Oct; 96(10):2784-94. PubMed ID: 17542017
[TBL] [Abstract][Full Text] [Related]
11. Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.
Amharar Y; Curtin V; Gallagher KH; Healy AM
Int J Pharm; 2014 Sep; 472(1-2):241-7. PubMed ID: 24968139
[TBL] [Abstract][Full Text] [Related]
12. Amorphous Protic Ionic Systems as Promising Active Pharmaceutical Ingredients: The Case of the Sumatriptan Succinate Drug.
Wojnarowska Z; Knapik J; Rams-Baron M; Jedrzejowska A; Paczkowska M; Krause A; Cielecka-Piontek J; Jaworska M; Lodowski P; Paluch M
Mol Pharm; 2016 Mar; 13(3):1111-22. PubMed ID: 26836258
[TBL] [Abstract][Full Text] [Related]
13. Application of a Salt Coformer in a Co-Amorphous Drug System Dramatically Enhances the Glass Transition Temperature: A Case Study of the Ternary System Carbamazepine, Citric Acid, and l-Arginine.
Ueda H; Wu W; Löbmann K; Grohganz H; Müllertz A; Rades T
Mol Pharm; 2018 May; 15(5):2036-2044. PubMed ID: 29630842
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of blends of paracetamol and citric acid.
Hoppu P; Jouppila K; Rantanen J; Schantz S; Juppo AM
J Pharm Pharmacol; 2007 Mar; 59(3):373-81. PubMed ID: 17331340
[TBL] [Abstract][Full Text] [Related]
15. Comparative Physical Study of Three Pharmaceutically Active Benzodiazepine Derivatives: Crystalline versus Amorphous State and Crystallization Tendency.
Valenti S; Barrio M; Negrier P; Romanini M; Macovez R; Tamarit JL
Mol Pharm; 2021 Apr; 18(4):1819-1832. PubMed ID: 33689364
[TBL] [Abstract][Full Text] [Related]
16. New processing technique for viscous amorphous materials and characterisation of their stickiness and deformability.
Hoppu P; Grönroos A; Schantz S; Juppo AM
Eur J Pharm Biopharm; 2009 May; 72(1):183-8. PubMed ID: 19068232
[TBL] [Abstract][Full Text] [Related]
17. A solid-state NMR study of phase structure, molecular interactions, and mobility in blends of citric acid and paracetamol.
Schantz S; Hoppu P; Juppo AM
J Pharm Sci; 2009 May; 98(5):1862-70. PubMed ID: 18802950
[TBL] [Abstract][Full Text] [Related]
18. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
[TBL] [Abstract][Full Text] [Related]
19. Thermal insight of mechanically activated bile acid powders.
Ito T; Byrn S; Chen X; Carvajal MT
Int J Pharm; 2011 Nov; 420(1):68-75. PubMed ID: 21872650
[TBL] [Abstract][Full Text] [Related]
20. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.
Hancock BC; Shamblin SL; Zografi G
Pharm Res; 1995 Jun; 12(6):799-806. PubMed ID: 7667182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
